Presentation is loading. Please wait.

Presentation is loading. Please wait.

Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement 

Similar presentations


Presentation on theme: "Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement "— Presentation transcript:

1 Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement  Rubie Sue Jackson, MD, MPH, Anton N. Sidawy, MD, MPH, Richard L. Amdur, PhD, Akhil Khetarpal, MS, Robyn A. Macsata, MD  Journal of Vascular Surgery  Volume 54, Issue 6, Pages (December 2011) DOI: /j.jvs Copyright © Terms and Conditions

2 Fig 1 Subject inclusion/exclusion. AV, Arteriovenous.
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

3 Fig 2 Autogenous (A) and prosthetic (B) arteriovenous (AV) access primary patency, in angiotensin receptor blocker (ARB) users and nonusers. Shaded areas indicate 95% confidence interval (CI). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions


Download ppt "Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement "

Similar presentations


Ads by Google